搜索筛选:
搜索耗时1.3325秒,为你在为你在102,285,761篇论文里面共找到 49 篇相符的论文内容
发布年度:
Predictions about probabilities of adverse events and appropriate dose of roflumilast for Chinese CO
[会议论文] 作者：Xinge Cui,Xin Zheng,Pei Hu,Ji Jiang,
来源：第五届定量药理学与新药评价国际会议 年份：2015
Backgrounds: Roflumilast is an oral inhibitor of phosphodiesterase 4(PDE4), which is mainly metabolized by CYP3A4 and CYP1A2.The main metabolite of it is roflumilast N-oxide, which contributes to the...
OBSERVATIONS OF PLASMA ARGININE,ADMA AND SDMA CONCENTRATIONS IN RELATION TO RENAL FUNCTION IN BURN P
[会议论文] 作者：Hongyun WANG,Ji JIANG,Pei HU,Yongming YU,Ronald G.TOMPKINS,
来源：2009第十三届北京分析测试学术报告会 年份：2009
...
Predicting whole blood concentrations of zonisamide in human using a physiologically based pharmacok
[会议论文] 作者：Xin Zheng,Kairui Feng,Pei Hu,Ji Jiang,Jun Shi,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium 年份：2013
...
OBSERVATIONS OF PLASMA ARGININE,ADMA AND SDMA CONCENTRATIONS IN RELATION TO RENAL FUNCTION IN BURN P
[会议论文] 作者：Hongyun WANG,Ji JIANG,Pei HU,Yongming YU,Ronald G.TOMPKINS,
来源：2009第十三届北京分析测试学术报告会 年份：2009
...
Development and validation a PBPK model to predict age-dependent PK for Chinese subjects-a case stud
[会议论文] 作者：Hongyun Wang,Xia Chen,Jun Shi,Ji Jiang,Pei Hu,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份：2013
Aim:Todevelop and validate a general physiologicallybased pharmacokinetic (PBPK) model for hepatic pathway in Chinese adults at various ages, and to evaluate it with midazolam (substrate of CYP3A4) as...
[会议论文] 作者：Jia Chen,Dongyang Liu,Qian Zhao,Ji Jiang,Pei Hu,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份：2013
Objective:Icotinib is a potent small-molecule inhibitor of epidermal growth factor receptor (EGFR)-tyrosine kinase (TKI), which was designed for the treatment of non-small cell lung cancer (NSCLC).It...
A semi-mechanistic population pharmacokinetic model describing the time-dependent kinetics of Red Bl
[会议论文] 作者：Kairui Feng,Xin Zheng,Wenyuan Qi,Pei Hu,Ji Jiang,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份：2013
Background: XQ (Carfree, Nanjing, China), a new chemical entity that possesses pharmacological activity on PlateletActivating Factor (PAF).XQ was approved into phase Ⅰ evaluation for treatment of isch...
A Mechanistic Pharmacokinetic-Pharmacodynamic Model for the Effect of Esomeprazole in Healthy Subjec
[会议论文] 作者：Dongyang Liu,Hong Yang,Jiaming Qian,Ji Jiang,Pei Hu,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份：2013
Esomeprazole has proved to be effective for the treatment of gastroesophogeal reflux disease (GERD) and ulcers, where intra-gastric pH value is a biomarker to indicate esomeprazole effects on these di...
Population pharmacokinetic/pharmacodynamic Modeling for Pegylated Recombinant Human Growth Hormone (
[会议论文] 作者：Xin Zheng,Tao Liu,Qian Zhao,Pei Hu,Ji Jiang,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份：2013
Objective:CPRC-Y is a pegylatedrecombinant human growth hormone (rhGH) developed with the aim of reducing serum clearance and thereby prolonging the exposure leading to once-weekly sc administration.T...
Predicting whole blood concentrations of zonisamide in human using a physiologically based pharmacok
[会议论文] 作者：Xin Zheng,Kairui Feng,Pei Hu,Jun Shi,Ji Jiang,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份：2013
Background:Concentration dependent Blood to plasma ratio (B/P) of zonisamide(ZNS) was observed in clinical trial, which requires measuring both plasma concentration and whole blood concentration for c...
[会议论文] 作者：Rui Chen,Dongyang Liu,Jun Shi,Ji Jiang,Pei Hu,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份：2013
Objective:In vitro information on dextromethorphan (DXM) and the Advanced Dissolution Absorption Metabolism (ADAM) model, incorporated into PBPK simulator Simcyp(@) (v.12) were used to investigate dif...
ROHACELL SANDWICH STRUCTURES FOR AUTOMOTIVE SERIAL APPLICATIONS - LIGHTEST DESIGN, ROBUST SIMULATION
[会议论文] 作者：Arnim Kraatz,Uwe Lang,Stefan Plass,Matthias Alexander Roth,Pei Hu,
来源：材料与过程促进会SAMPE中国年会 年份：2011
One focus of automotive industry is to reduce the weight of cars especially for electric vehicles (EV). ROHACELL?composite structures offer a significant weight...
[会议论文] 作者：Yan Li,Shan Kang,Pei Hu,RongMiao Zhou,Na Wang,HaiYan Sun,
来源：第十三次全国妇科肿瘤学术会议 年份：2012
...
Assessing ethnic sensitivity by simulating pharmacokinetics in virtual Caucasian and Chinese populat
[会议论文] 作者：Sheng Feng,Yumi Fukushima,Pei Hu,Conni Weber,Yongqing Wang,Jun Shi,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份：2013
Background and Rationale: Physiologically-based pharmacokinetics (PBPK) modelling is a key component of model-based drug development and is increasingly embraced within the industry and regulatory aut...
Effect of Target-Mediated Drug Disposition on CPRC3 Pharmacokinetics and Pharmacodynamics in Healthy
[会议论文] 作者：Zhenlei Wang,Qian Zhao,Dongyang Liu,Yupeng Ren,Ji Jiang,Pei Hu,
来源：第五届定量药理学与新药评价国际会议 年份：2015
Background: The prevalence of diabetes mellitus (DM) dramatically increased over the past decades.Dipeptidyl peptidase Ⅳ (DPP-4) inhibitors are a relatively new group of anti-diabetic agents.CPRC3 is...
[会议论文] 作者：Yingxiang Wang,Don Zhang,Li Zhang,Pei Hu,Dongyang Liu,Ji Jiang,Fenlai Tan,
来源：2009年亚太地区肿瘤生物学和医学学术会议暨第四届中国中青年肿瘤专家论坛 年份：2009
...
The study of association between ERCC1 polymorphism and clinical outcome of epithelial ovarian cance
[会议论文] 作者：pei hu,yan li,na wang,Yu Cao,rongmiao zhou,bingli qi,shan kang,
来源：第十三次全国妇科肿瘤学术会议 年份：2012
...
Quantitative Estimation of Stratum Corneum Drug Content Obtained Through Tape Stripping and Its Appl
[会议论文] 作者：Wen Zhong,Xia Chen,Qian Zhao,Ji Jiang,Tao Liu,Hong-zhong Liu,Pei Hu,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份：2013
Background: Dermatopharmacokinetic (DPK) bioequivalence (BE) evaluation required assessments of stratum corneum (SC) drug content.The SC samples are normall...
[会议论文] 作者：Dongyang Liu,Ji Jiang,Fenlai Tan,Yingxiang Wang,Don Zhang,Li Zhang,Pei Hu,
来源：2009年亚太地区肿瘤生物学和医学学术会议暨第四届中国中青年肿瘤专家论坛 年份：2009
...
Sequential Population Pharmacokinetic and Pharmacodynamic Modeling of Rivaroxaban in Adult and Elder
[会议论文] 作者：Tao Liu,Ji Jiang,Xin Zheng,Qian Zhao,Xia Zhao,Yimin Cui,Pei Hu,
来源：第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份：2013
Aim:Rivaroxaban (Bayer Healthcare AG, Wuppertal, Germany), an oral, direct factor Xa (FXa) inhibitor for the prevention and treatment of thromboembolic disorders has been approved for nonvalvular atri...
相关搜索：
